Cite
MLA Citation
David Fogelman et al.. “Randomized, double‐blind, phase two study of ruxolitinib plus regorafenib in patients with relapsed/refractory metastatic colorectal cancer.” Cancer medicine, vol. 7, n.d., pp. 5382–5393. http://access.bl.uk/ark:/81055/vdc_100072623890.0x00000a